GeneTex
United States (US)

VEGF antibody

VEGF-antibody_WB_GTX29570-1_18121411_333.jpg

Cat No. GTX29570

Host Rabbit
Clonality Polyclonal
Application WB, ELISA, Neut
Reactivity Human
APPLICATION

Application Note

Suggested concentration: Elisa: 2-3 μg/ml; Neutralization: 5-10 μg/ml; WB: 0.5-1 μg/ml. However, the optimal conditions should be determined individually.
PROPERTIES

Form

Liquid

Buffer

PBS, pH 7.2, containing 30% glycerol and 0.01% thimerosal.

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Concentration

0.5 mg/ml (Please refer to the vial label for the specific concentration.)

Antigen Species

Human

Immunogen

E. coli expressed recombinant human VEGF

Purification

Immunogen affinity purified

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

VEGFA, VPF, 125853, 7422, P15692, MGC70609, VEGF

Cellular Localization

Secreted

Background

Vascular Endothelial Cell Growth Factor (VEGF) is a secreted homodimeric protein, secreted by a variety of vascularized tissues. The reported activities include stimulation of endothelial cell growth, angiogenesis, and capillary permeability. VEGF in serum is a prognostic indicator of the presence of cancer
DATA IMAGES
VEGF-antibody_WB_GTX29570-1_18121411_333.jpg

GTX29570 WB Image

Western blot analysis with recombinant His-Tagged VEGF protein
Lane 1: 10 ng rh-VEGF
Lane 2: 50 ng rh-VEGF
Lane 3: 250 ng rh-VEGF
Lane 4: 1µg rh-VEGF

Package List Price ($)
$ 329